A decade of FDA approvals for pediatric cancer indications: What have we learned?
Objective: The present analysis reviews a decade of cancer drug approvals for pediatric indications in the United States, and aims to determine the impact of legislative initiatives, including the Pediatric Research Equity Act (PREA), the Research to Accelerate Cures and Equity (RACE) for Children A...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | EJC Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X2300003X |